Literature DB >> 11559323

What matters is not the differences between triptans, but the differences between patients.

J R Saper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11559323     DOI： 10.1001/archneur.58.9.1481

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  5 in total

Review 1.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 3.  Rizatriptan: an update of its use in the management of migraine.

Authors:  Keri Wellington; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Newer formulations of the triptans: advances in migraine management.

Authors:  Jonathan Paul Gladstone; Marek Gawel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Triptans: do they differ?

Authors:  Reijo Salonen; Andrew Scott
Journal:  Curr Pain Headache Rep       Date:  2002-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.